Identification of differentially expressed genes in rat aortic allograft vasculopathy.
Graft vasculopathy is an important complication of long-surviving organ transplants, but its pathogenesis has remained elusive. We investigated rat aortic transplants with vasculopathy, aortic transplants without vasculopathy, and normal aortas for differentially expressed mRNA transcripts to gain further insight into the molecular mechanisms involved. Aortic transplants were performed in allogeneic or syngeneic recipients followed by removal after 1 or 5 months, RNA isolation, and differential display to identify mRNA transcripts the expression of which was modulated in conjunction with the transplant procedure and the development of vasculopathy. Using 80 random primers, 57 differentially displayed polymerase chain reaction products were identified, 18 of which were found in allografts but not in syngeneic grafts or normal vessels, whereas 15 were expressed in normal vessels and syngeneic grafts but not in allografts. Of the differentially displayed amplicons, 13 were successfully reamplified and used as probes for Northern analysis; differential expression was confirmed in 6 instances. DNA sequence analysis of these PCR products revealed identity with the immunoglobulin J chain in 2 instances, the ferritin heavy chain, a sequence related but not identical with Ras, and an established sequence tag recently isolated from a human fetal heart library; 1 sequence was not related to any known gene. To assess whether differential mRNA expression of the J-chain gene, a gene expressed in cells of B lymphocyte lineage, was associated with infiltration of the graft by B lymphocytes, tissue sections were stained with an antibody against the B cell marker CD45RA. Although the number of CD45RA-positive cells was low, there was a significant increase in the number of CD45RA-positive cells in the adventitia and intima of grafts with vasculopathy. Furthermore, immunostaining with anti-ferritin antiserum confirmed the presence of ferritin-positive cells within the inner layer of the graft vessel wall and dispersed in the intima, media, and adventitia. The question remains as to which of these genes are critically relevant in the pathogenesis of graft vasculopathy and whether they serve as targets for therapeutic interventions.
Chen
J
J
Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
Myllärniemi
M
M
Akyürek
L M
LM
Häyry
P
P
Marsden
P A
PA
Paul
L C
LC
D000818:Animals; D001012:Aorta, Abdominal / Q000473:pathology / Q000637:transplantation*; D001483:Base Sequence; D015152:Blotting, Northern; D018076:DNA, Complementary / Q000302:isolation & purification; D004714:Endometrial Hyperplasia / Q000209:etiology / Q000235:genetics* / Q000473:pathology; D005260:Female; D005293:Ferritins / Q000032:analysis; D005786:Gene Expression Regulation / Q000235:genetics*; D007120:Immunochemistry; D007124:Immunoenzyme Techniques; D017493:Leukocyte Common Antigens / Q000032:analysis; D008297:Male; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D013997:Time Factors; D014184:Transplantation, Homologous / Q000009:adverse effects; D014185:Transplantation, Isogeneic / Q000009:adverse effects; D017539:Tunica Intima / Q000473:pathology
D018076:DNA, Complementary; D012333:RNA, Messenger; D005293:Ferritins; D017493:Leukocyte Common Antigens